The United States Food and Drug Administration (FDA) has issued an official warning to multiple companies, prohibiting them from selling e-cigarettes and other products to minors, including two products highlighted in STAT's recent industry report.
In August, STAT reported that Wizman Limited was one of the companies issued a warning by the FDA for selling an e-cigarette that looks like a handheld video game. STAT also reported on Tuesday that an e-cigarette with a "meme-inspired" theme produced by Shenzhen Fumot Technology Co. Ltd. was being sold just a few miles from the FDA's campus. The company received its first warning from the FDA on Wednesday.
The design of these products is a clear attempt to market to children," said Brian King, director of the FDA's Center for Tobacco Products, in a statement. "Encouraging adults trying to quit smoking to use e-cigarettes with cartoon designs is a bit of a stretch.
However, it is unclear if the warning is enough to force these products off the market. For instance, Wizman received a warning from the FDA in April 2020 and briefly halted sales of their product, but later resumed selling quietly.
Today, other companies that received warnings include Myle, a Chinese fashion electronic cigarette manufacturer with designs similar to Juul and Vuse, whose ads are sold in over 100,000 retail stores worldwide, as well as Ruthless Vapor, a California-based company whose disposable electronic cigarette looks like a banana.
Statement:
This article is compiled from third-party sources and is intended for industry-related discussions and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of its contents. The compilation of this article is only intended for industry-related communication and research purposes.
Due to limitations in translation skills, the compiled article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign related statements and positions.
The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
